We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




European Commission Funds Development of Patient-Friendly Endoscopy System

By Labmedica staff writers
Posted on 09 Feb 2007
A group of nine European companies and universities have been awarded a multimillion-euro research contract to develop a patient-friendly, highly sensitive screening system for the detection of early cancer and pre-cancerous conditions in the gastrointestinal tract. More...
The Nano-based capsule-Endoscopy with Molecular Imaging and Optical biopsy (NEMO) project will be funded under the auspices of the European Commission of the Sixth EU Framework Program of Research and Technological Development (FP6 commission).

The NEMO project is based on the Given Imaging (Yoqneam, Israel) PillCam video capsule. This device comprises a disposable, miniature video camera contained in a capsule, which is ingested by the patient, a sensor array, data recorder, and dedicated software.

Several of the research partners are engineering firms whose task will be to upgrade and enhance the electronic and mechanical systems built into the capsule. Another aspect of the project is the insertion or attachment of an immunodiagnostic test to the capsule that will allow real-time diagnosis of lesions spotted by capsule video. Novamed Ltd. (Jerusalem, Israel) is leading this section of the project in cooperation with hospitals and clinical laboratories in Germany and Italy.

We are proud to advance our research in the bio-sensing field with such leading research and industrial organizations,” said Dr. Elisha Rabinovitz, chief scientist of Given Imaging. "This project further exemplifies Given's commitment to develop new and innovative solutions to help physicians treat their patients and could represent a revolutionary platform of biopsy-free procedures.”




Related Links:
Given Imaging
Novamed Ltd.

Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Genetic Type 1 Diabetes Risk Test
T1D GRS Array
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.